HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Galluzzo, P. Articles by Marino, M. Search for Related Content PubMed PubMed Citation Articles by Galluzzo, P. Articles by Marino, M.

Department of Biology, University ‘Roma Tre’, Viale G Marconi, 446,I-00146 Roma, Italy

(Requests for offprints should be addressed to M Marino; Email: m.marino{at}uniroma3.it)

The cellular functions regulated by 17ß-estradiol (E2) start after the hormone binds to its receptors (i.e., ER and ERß ). These act as ligand-dependent transcription factor transactivating target genes. In addition, E2 induces non-genomic actions, whose activation is triggered by a fraction of the ERs localized at the plasma membrane. Palmitoylation allows ER to localize at the plasma membrane, to associate with caveolin-1, and, upon E2 stimulation, to activate rapid signals relevant for cell proliferation. The existence of a mechanism, which allows ERß localization at the plasma membrane and its putative role in anti-proliferative E2 effects is completely unknown. Here, the susceptibility of ERß to undergo palmitoylation and the role played by this process has been analyzed in DLD-1 containing endogenous ERß or in HeLa cells transiently transfected with ERß or ER expression vectors. As for ER , palmitoylation is necessary for ERß localization at the plasma membrane and its association with caveolin-1 but, in contrast to ER , the E2 binding increases ERß association with caveolin-1 and the p38 member of MAPK family. Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERß –E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage). Consequently, palmitoylation must be considered to be a molecular device for ERß , which allows these receptors to interact with the plasma membrane and to regulate E2-induced non-genomic functions relevant to the anti-proliferative effect of this hormone.

This article has been cited by other articles:

				P. Galluzzo, P. Ascenzi, P. Bulzomi, and M. Marino The Nutritional Flavanone Naringenin Triggers Antiestrogenic Effects by Regulating Estrogen Receptor {alpha}-Palmitoylation Endocrinology, May 1, 2008; 149(5): 2567 - 2575. [Abstract] [Full Text] [PDF]